ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Imaging Technique Identifies Consequences Of Mutation

February 24, 2012

Payline For 1988 Would Be Around 160 With President’s Budget

January 16, 1987

Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says

May 3, 2002

DCT Advisors Approve Increased Spending On Trials Monitoring

May 6, 1994

FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise”

January 7, 1977

Shubik applauded for NCAB Service

February 12, 1982